Stocks
Attovia Therapeutics, Inc.ATTO
NASDAQHealthcareBiotechnology$14.50
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing multispecific antibodies for inflammatory and autoimmune diseases. Its lead candidate targets IL-13 and IL-31 pathways, with early-stage data expected in the next 12 to 18 months. Investors track the stock for its potential in the atopic dermatitis and chronic pruritus markets.
52W Range: $12.94-$28.00
Congressional Interest in Attovia Therapeutics, Inc. (ATTO)
No congressional trades have been disclosed for Attovia Therapeutics, Inc. (ATTO) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ATTO?
No congressional trades found for this stock.